Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Evaluation of a quantitative determination of CD4 and CD8 molecules as an alternative to CD4+ and CD8+ T lymphocyte counts in Africans.

Trop Med Int Health. 1999 Feb;4(2):79-84. Unique Identifier : AIDSLINE MED/99221101
Diagbouga S; Durand G; Sanou PT; Dahourou H; Ledru E; Centre MURAZ, Organization de Coordination et de Cooperation; pour la lutte contre les Grandes Endemies, Bobo-Dioulasso,; Burkina Faso. griv.muraz@fasonet.bf


Abstract: In the developed word, monitoring HIV-infected patients is routinely determined by CD4+ T lymphocyte absolute counts. The reference procedure, flow cytometry, is expensive, requires sophisticated instrumentation and operators with specific training. Due to these limitations, CD4 counting is often unavailable in developing countries. The Capcellia assay is an enzyme-linked immunoassay for quantitative determination of CD4 and CD8 molecules. We evaluated this method in West Africa on blood samples collected from 39 HIV-uninfected and 44 HIV-infected adult subjects. CD4 concentration ranges were determined according to the clinical stages of the disease. We then studied the relationship between the two methods in the HIV-infected patients. The Spearman's rank correlation was 0.61 (95% confidence interval: 0.38-0.76, P < 0.0001). Nevertheless, determination of limits of agreement revealed discrepancies between the two methods, especially for CD4 counts > 0.4 x 10(9)/l, which are discussed. We conclude that the Capcellia assay is a convenient means to determine the immunodepression level where flow cytometric instrumentation is unavailable, and can be complementary to CD4 T lymphocyte enumeration.
Keywords: JOURNAL ARTICLE Adult Africa, Western Antibodies, Monoclonal Antigens, CD4/*BLOOD Antigens, CD8/*BLOOD Comparative Study CD4 Lymphocyte Count CD8-Positive T-Lymphocytes Enzyme-Linked Immunosorbent Assay/*METHODS Evaluation Studies Flow Cytometry Human HIV Infections/BLOOD/*IMMUNOLOGY HIV-1 *Lymphocyte Count Reagent Kits, Diagnostic Support, Non-U.S. Gov'tKWDjournalarticleadultafrica,westernantibodies,monoclonalantigens,cd4/KWDbloodantigens,cd8/KWDbloodcomparativestudycd4lymphocytecountcd8-positivet-lymphocytesenzyme-linkedimmunosorbentassay/KWDmethodsevaluationstudiesflowcytometryhumanhivinfections/blood/KWDimmunologyhiv-1KWDlymphocytecountreagentkits,diagnosticsupport,non-uKWDsKWDgov't
990730
A9971181

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .